Afriplex Releasing First SA-Developed Rooibos API (Active Pharmaceutical Ingredient)
Afriplex (Pty) Ltd, regarded one of the leaders in API development and production in South Africa, has partnered with the South African Medical Research Council (SAMRC) and Agricultural Research Council (ARC) to develop Afriplex GRT™. The end result is Afriplex GRT™, an active pharmaceutical ingredient (API) that will use naturally occurring flavonoid compounds found in rooibos to target specific metabolic syndrome-related dysfunctions in the body. Afriplex GRT™ is regarded as the first of its kind to be developed in South Africa. According to the World Health Organisation (WHO), the number of people with diabetes has risen from 108 million in 1980...
Afriplex Returning to Its Roots as African Botanical Extracts Suppliers
[vc_row css=".vc_custom_1517459872281{padding-bottom: 10px !important;}"][vc_column][vc_column_text] After Aligning Itself With Role-Players In The International Food Supplement Arena, Afriplex Is Returning To Its Roots - Roots That Are Secured By Years Of Experience And Knowledge Of African Botanicals And Extraction Technology. The Company Would Like To Announce That It Will Again Be Supplying Its Well- Established African Botanicals And Extract Range To Its Customers. These Extracts Were Historically Developed For Applications In Various Industries, But With A Strong Focus On Client-Specific Tailoring. Over the past three years Afriplex has expanded its capacity and acquired additional technology, allowing for the production of not only standardized extracts,...